Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor function
Open Access
- 10 February 2000
- journal article
- research article
- Published by Springer Nature in Oncogene
- Vol. 19 (6) , 810-820
- https://doi.org/10.1038/sj.onc.1203409
Abstract
A number of epidermal growth factor receptor (EGFR) deletion mutants have been identified in gliomas, in which the EGFR gene is frequently amplified and rearranged. We have previously characterized the structure of a gene in A-172 human glioma cells that encodes a 190-kDa EGFR mutant with tandem duplication of the tyrosine kinase (TK) and calcium-mediated internalization (CAIN) domains. Here we describe a 185-kDa tandem duplication mutant (TDM) that is expressed in KE and A-1235 glioma cells, along with certain functional characteristics of the mutants. The corresponding transcripts in KE and A-1235 cells contain 1053 additional nucleotides representing an in-frame duplication of exons 18 through 25 which encode the entire TK region and a portion of the CAIN domain. As with duplication of the entire TK/CAIN region (exons 18–26) in A-172 cells, duplication of exons 18–25 is associated with a specific genomic rearrangement between flanking introns. Involved introns contain homology to recombination signal sequence (RSS) heptamers present in the V(D)J region of the T lymphocyte receptor gene. In defined medium, both oncogenic TDM are constitutively autophosphorylated and inefficiently downregulated. High-affinity binding is reduced in EGFR.TDM/18–26, although the t½ of receptor internalization is not prolonged.Keywords
This publication has 26 references indexed in Scilit:
- Tandem duplication of the epidermal growth factor receptor tyrosine kinase and calcium internalization domains in A-172 glioma cellsOncogene, 1998
- Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-X L and caspase-3-like proteasesProceedings of the National Academy of Sciences, 1998
- Differential Modulation of Mitogen-activated Protein (MAP) Kinase/Extracellular Signal-related Kinase Kinase and MAP Kinase Activities by a Mutant Epidermal Growth Factor ReceptorJournal of Biological Chemistry, 1995
- Deletion-mutant epidermal growth factor receptor in human gliomas: Effect of type II mutation on receptor functionBiochemical and Biophysical Research Communications, 1991
- Transforming growth factor-α, epidermal growth factor receptor, and proliferating potential in benign and malignant gliomasJournal of Neurosurgery, 1991
- Anti-synthetic peptide antibody reacting at the fusion junction of deletion-mutant epidermal growth factor receptors in human glioblastoma.Proceedings of the National Academy of Sciences, 1990
- Functional independence of the epidermal growth factor receptor from a domain required for ligand-induced internalization and calcium regulationCell, 1989
- Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cellsCell, 1987
- Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial originNature, 1985
- LIGAND: A versatile computerized approach for characterization of ligand-binding systemsAnalytical Biochemistry, 1980